https://www.selleckchem.com/products/arq-197.html
Serous (cystic) neoplasm (SCN) of the pancreas is generally benign, and surgical treatment is recommended only in limited cases. To avoid unnecessary surgery, an accurate diagnosis of SCN is essential. In the present study, we aimed to identify new immunohistochemical markers to distinguish SCN from other tumors. We compared the comprehensive gene expression profiles of SCN with those of normal pancreas and pancreatic ductal adenocarcinoma (PDAC). We selected the candidate molecules that were upregulated in SCN, minimally expressed or u
Like
Comment
Share
